Agenus Inc. 2016 Annual Report Form 10-K

Agenus Inc.'s 2016 annual report filed with the SEC detailing the biopharmaceutical company's business operations, financial performance, and risk factors. The report covers the company's research and development efforts, product candidates, intellectual property portfolio, and corporate governance for the fiscal year ended December 31, 2016.